Timothy Harvey

Timothy Harvey has worked in a variety of roles in the finance industry since 2011. In 2011, they began as a Risk Management Associate at INTL FCStone Inc. In 2012, they were promoted to Director at Talton Capital Management. From 2013 to 2018, they worked as an Institutional Equity Sales Trader at Weeden & Co. After that, they were an Executive Director at MKM Partners from 2018 to 2019. Most recently, in 2021, they became an Operating Partner at QDS Capital, a venture capital firm with offices in San Francisco, CA and Charlottesville, Virginia.

Timothy Harvey has a diverse educational background. Timothy graduated from the University of South Alabama in 2010 with a Bachelors of Science in Business Management, Politics, and Psychology. From 2012 to 2013, they attended Northwestern University for a Post-baccalaureate Program in Finance, General. Timothy then attended the Massachusetts Institute of Technology for a Drug and Medical Device Development: A Strategic Approach program. Most recently, they attended the University of Virginia Darden School of Business from 2018 to 2020 and obtained a Master of Business Administration (MBA). Timothy also attended Loyola Academy from 2002 to 2006. In addition to their educational background, Timothy Harvey has obtained several certifications, including Drug and Medical Device Development: A Strategic Approach from Emeritus in 2020, Series 3 from FINRA, Series 55 from FINRA, Series 63 from FINRA, and Series 7 from FINRA.